CTX-30916

N/A

Report date: 2025/01/26 18:21:13
NME

Base Information

Drug NameCTX-30916
Drug Alias Nameprogesterone receptor antagonist (Context Therapeutics)progesterone receptor antagonist (Context Therapeutics)CTX-30916
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgesterone receptor antagonists
TargetsProgesterone receptor
Therapy Area/IndicationsUterine FibroidsEndometriosisBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesContext Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesContext Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsUterine FibroidsEndometriosisBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A